Cargando…
Human pluripotent stem cell-derived β cells: Truly immature islet β cells for type 1 diabetes therapy?
A century has passed since the Nobel Prize winning discovery of insulin, which still remains the mainstay treatment for type 1 diabetes mellitus (T1DM) to this day. True to the words of its discoverer Sir Frederick Banting, “insulin is not a cure for diabetes, it is a treatment”, millions of people...
Autores principales: | Jiang, Helen, Jiang, Fang-Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173812/ https://www.ncbi.nlm.nih.gov/pubmed/37180999 http://dx.doi.org/10.4252/wjsc.v15.i4.182 |
Ejemplares similares
-
Functional maturation of immature β cells: A roadblock for stem cell therapy for type 1 diabetes
por: Sun, Zi-Yi, et al.
Publicado: (2021) -
Conformal Coating of Stem Cell-Derived Islets for β Cell Replacement in Type 1 Diabetes
por: Stock, Aaron A., et al.
Publicado: (2019) -
The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells?
por: Naqvi, Raza Ali, et al.
Publicado: (2023) -
The progress of pluripotent stem cell-derived pancreatic β-cells regeneration for diabetic therapy
por: Wang, Xin, et al.
Publicado: (2022) -
Pancreatic β-cell heterogeneity in adult human islets and stem cell-derived islets
por: Aldous, Noura, et al.
Publicado: (2023)